• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    Foundation Medicine, Inc. (FMI)

    47.66 Down 0.45(0.94%) 4:00PM EST
    Add to Portfolio
    CompetitorsGet Competitors for:
    Direct Competitor Comparison 
    Market Cap:1.35BN/A1.02B2.73B289.44M
    Qtrly Rev Growth (yoy):1.00N/A0.05-0.170.16
    Revenue (ttm): 52.06MN/A275.40M744.59M96.64M
    Gross Margin (ttm):0.55N/A0.780.840.45
    EBITDA (ttm):-44.86MN/A-19.38M247.48M4.84M
    Operating Margin (ttm): -1.01N/A-0.090.31-0.03
    Net Income (ttm):-52.02MN/A-27.69M136.74MN/A
    EPS (ttm):-1.87N/A-0.891.78N/A
    P/E (ttm):N/AN/AN/A21.0825.81
    PEG (5 yr expected):N/AN/A2.051.801.63
    P/S (ttm):26.16N/A3.733.762.96
    Pvt1 = Clarient, Inc. (privately held)
    GHDX = Genomic Health Inc.
    MYGN = Myriad Genetics Inc.
    Industry = Medical Laboratories & Research

    News on Direct Competitors 

    Currency in USD.